Paul V. Maier, Senior V-P, CFO at LIGAND PHARMACEUTICALS INC (LGND), sold 38,148 shares at $11.55 ($437K) on 2006-11-17, disclosed to the SEC on 2006-11-21.
Open-market sale of $437k LGND by Senior V-P, CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.28 | 300 | $3K | 0.8% |
| 2 | $11.29 | 200 | $2K | 0.5% |
| 3 | $11.29 | 607 | $7K | 1.6% |
| 4 | $11.30 | 100 | $1K | 0.3% |
| 5 | $11.30 | 300 | $3K | 0.8% |
| 6 | $11.31 | 1,600 |
| $18K |
| 4.1% |
| 7 | $11.31 | 500 | $6K | 1.3% |
| 8 | $11.32 | 900 | $10K | 2.3% |
| 9 | $11.33 | 300 | $3K | 0.8% |
| 10 | $11.34 | 1,100 | $12K | 2.9% |
| 11 | $11.34 | 2,000 | $23K | 5.2% |
| 12 | $11.35 | 600 | $7K | 1.6% |
| 13 | $11.36 | 111 | $1K | 0.3% |
| 14 | $11.39 | 600 | $7K | 1.6% |
| 15 | $11.47 | 500 | $6K | 1.3% |
| 16 | $11.48 | 600 | $7K | 1.6% |
| 17 | $11.49 | 800 | $9K | 2.1% |
| 18 | $11.50 | 7,148 | $82K | 18.8% |
| 19 | $11.50 | 3,375 | $39K | 8.9% |
| 20 | $11.50 | 5,007 | $58K | 13.2% |
| 21 | $11.51 | 3,700 | $43K | 9.7% |
| 22 | $11.52 | 600 | $7K | 1.6% |
| 23 | $11.53 | 938 | $11K | 2.5% |
| 24 | $11.53 | 862 | $10K | 2.3% |
| 25 | $11.54 | 4,300 | $50K | 11.3% |
| 26 | $11.55 | 600 | $7K | 1.6% |
| 27 | $11.62 | 500 | $6K | 1.3% |
| Total | $11.47 avg | 38,148 | $437K | 100% |
| Filing → |
| ETON | BUY | 2018-11-15 | $30K | — | Filing → |
| MBVX | SELL | 2018-01-24 | $30K | — | Filing → |
| MBVX | BUY | 2015-06-02 | $12K | — | Filing → |